CCT-368408

N/A

Report date: 2025/01/26 19:30:28
NME

Base Information

Drug NameCCT-368408
Drug Alias NameDual ALK/BRD4 inhibitor (Institute of Cancer Research)CCT-368408
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 4 degradersAnaplastic lymphoma kinase inhibitors
TargetsBromodomain-containing protein 4Anaplastic lymphoma kinase
Therapy Area/IndicationsNeuroblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Cancer Research
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Cancer Research
Inactive CompaniesN/A
Active IndicationsNeuroblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A